Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pharmacology and Therapeutics

• Publication date

  2016-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.pharmthera.2015.12.001PMID 26706243
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolation of a novel chronic lymphocytic leukemic (CLL) cell line and development of an in vivo mouse model of CLL.

  2016cited by this paper
• Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update

  2015cited by this paper
• A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer.

  2015cited by this paper
• Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells

  2015cited by this paper
• Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency

  2015cited by this paper
• The emerging role of microRNAs in resistance to lung cancer treatments.

  2015cited by this paper
• Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma.

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer

  2014cited by this paper
• Both Canonical and Non-Canonical Wnt Signaling Independently Promote Stem Cell Growth in Mammospheres

  2014cited by this paper
• A phase 1 study evaluating the safety and efficacy of DKN-01, an investigational monoclonal antibody (Mab) in patients (pts) with advanced non-small cell lung cancer.

  2014cited by this paper
• Evolution of the cancer stem cell model.

  2014cited by this paper
• The effects of sonic hedgehog signaling pathway components on non-small-cell lung cancer progression and clinical outcome

  2014cited by this paper
• Targeting notch signaling pathway in cancer: clinical development advances and challenges.

  2014cited by this paper
• Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.

  2014cited by this paper
• The role of DNA repair pathways in cisplatin resistant lung cancer.

  2014cited by this paper
• CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist.

  2014cited by this paper
• EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling.

  2014cited by this paper
• Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells.

  2014cited by this paper
• First microRNA mimic enters clinic

  2013cited by this paper
• Medical treatment of small cell lung cancer: state of the art and new development

  2013cited by this paper
• Cancer stem cells: The challenges ahead

  2013cited by this paper
• Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines

  2013cited by this paper
• Regulatory networks defining EMT during cancer initiation and progression

  2013cited by this paper
• Evidence for tankyrases as antineoplastic targets in lung cancer

  2013cited by this paper
• Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

  2013cited by this paper
• A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.

  2013cited by this paper
• Notch Pathway Activity Identifies Cells with Cancer Stem Cell–like Properties and Correlates with Worse Survival in Lung Adenocarcinoma

  2013cited by this paper
• XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway

  2013cited by this paper
• WNT signaling in bone homeostasis and disease: from human mutations to treatments

  2013cited by this paper
• Thomas F. Gajewski and F. Stephen Hodi (eds): Targeted therapeutics in melanoma. Current clinical oncology, Series edited by Maurie Markman

  2013cited by this paper
• The relationship between tumor stem cells marker CD90 and resistance to cisplatin in human lung adenocarcinoma A549 cells

  2013cited by this paper
• Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors

  2013cited by this paper
• Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines.

  2013cited by this paper
• ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9

  2013cited by this paper
• Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature

  2013cited by this paper
• Randomized phase II trial of sulindac for lung cancer chemoprevention.

  2013cited by this paper
• Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer

  2013cited by this paper
• Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling.

  2013cited by this paper
• γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer

  2012cited by this paper
• Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.

  2012cited by this paper
• Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs

  2012cited by this paper
• High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells

  2012cited by this paper
• The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.

  2012cited by this paper
• Effects of the Hedgehog pathway inhibitor GDC-0449 on lung cancer cell lines are mediated by side populations

  2012cited by this paper
• WIKI4, a Novel Inhibitor of Tankyrase and Wnt/ß-Catenin Signaling

  2012cited by this paper
• A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice.

  2012cited by this paper
• Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis.

  2012cited by this paper
• Vaccination therapy for non-small-cell lung cancer: review of agents in phase III development.

  2012cited by this paper
• β-Catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial–mesenchymal transition

  2012cited by this paper
• Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer

  2012cited by this paper
• Cancer stem cell vaccination confers significant antitumor immunity.

  2012cited by this paper
• Mesenchymal stem cell-like cells in classic renal angiomyolipoma.

  2012cited by this paper
• Expression of Hedgehog Pathway Components is Associated with Bladder Cancer Progression and Clinical Outcome

  2012cited by this paper
• Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells

  2012cited by this paper
• Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2‐positive cancer cells and cancer stem cells

  2012cited by this paper
• Expression of hedgehog signaling molecules as a prognostic indicator of oral squamous cell carcinoma

  2012cited by this paper
• Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• Targeting pancreatic cancer stem cells for cancer therapy.

  2012cited by this paper
• Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors.

  2012cited by this paper
• The molecular basis of synergism between carboplatin and ABT-737 therapy targeting ovarian carcinomas.

  2011cited by this paper
• Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC.

  2011cited by this paper
• Hedgehog-producing cancer cells respond to and require autocrine Hedgehog activity.

  2011cited by this paper
• Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations.

  2011cited by this paper
• Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think

  2011cited by this paper
• Stem cell gene expression programs influence clinical outcome in human leukemia

  2011cited by this paper
• CD133 Protein N-Glycosylation Processing Contributes to Cell Surface Recognition of the Primitive Cell Marker AC133 Epitope*

  2011cited by this paper
• CD90 is Identified as a Candidate Marker for Cancer Stem Cells in Primary High-Grade Gliomas Using Tissue Microarrays*

  2011cited by this paper
• The Molecular Basis of Synergism between Carboplatin and 3 ABT-737 Therapy Targeting Ovarian Carcinomas

  2011cited by this paper
• Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer‐derived CD133‐positive cells

  2011cited by this paper
• Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells

  2011cited by this paper
• Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.

  2011cited by this paper
• Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis

  2011cited by this paper
• Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer

  2010cited by this paper
• Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases.

  2010cited by this paper
• Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator.

  2010cited by this paper
• Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties

  2010cited by this paper
• Requirement of TGFβ Signaling for SMO-mediated Carcinogenesis*

  2010cited by this paper
• Resistance to caspase-8 and -9 fragments in a malignant pleural mesothelioma cell line with acquired cisplatin-resistance

  2010cited by this paper
• Image-based chemical screening identifies drug efflux inhibitors in lung cancer cells.

  2010cited by this paper
• The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.

  2010cited by this paper
• Novel metals and metal complexes as platforms for cancer therapy.

  2010cited by this paper
• Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.

  2010cited by this paper
• Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.

  2010cited by this paper
• Chronic DLL4 blockade induces vascular neoplasms

  2010cited by this paper
• Shifting in balance between osteogenesis and adipogenesis substantially influences hematopoiesis.

  2010cited by this paper
• Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer Chemotherapy

  2010cited by this paper
• Planar cell polarity pathway genes and risk for spina bifida

  2010cited by this paper
• Targeting Hedgehog — a Cancer Stem Cell Pathway

  2010cited by this paper
• Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

  2010cited by this paper
• MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer

  2010cited by this paper
• Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer

  2010cited by this paper
• Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

  2009cited by this paper
• A new step ahead for the consideration of ERCC1 as a candidate biomarker to select NSCLC patients for the treatment of cetuximab in combination with cisplatin

  2009cited by this paper
• Stem cells, self-renewal, and differentiation in the intestinal epithelium.

  2009cited by this paper
• Limited copy number - high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies

  2009cited by this paper
• Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

  2009cited by this paper
• WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells

  2009cited by this paper
• High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth

  2009cited by this paper

• A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4

  2026cites this paper
• N6-Methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549 cells

  2026cites this paper
• A third-generation rhodium-based nanophotosensitizer for precision photodynamic cancer therapy.

  2026cites this paper
• Multimerization approach to improve a cell surface plectin binding cancer stem cell targeted peptoid drug‑lead.

  2026cites this paper
• DNMT3A triggers tumorigenesis of non-small cell lung cancer through regulation of SLIT2 methylation and SLIT2-mediated macrophage M1/M2 polarization.

  2025cites this paper
• HES1 in cancer: a key player in tumorigenesis and its prognostic significance

  2025cites this paper
• Berberine restrained proliferation, invasion, and migration by targeting the glycogen synthase kinase 3β/β-catenin pathway in lung adenocarcinoma cells

  2025cites this paper
• Autophagy in adult stem cell homeostasis, aging, and disease therapy

  2025cites this paper
• [Mechanistic research progress on radiotherapy resistance of cancer stem cells].

  2025cites this paper
• Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma

  2025cites this paper
• Emerging strategies in engineering nanomaterials for overcoming cancer stem cell-mediated therapy resistance

  2025cites this paper
• Construction of a prognostic model for lung adenocarcinoma based on disulfidptosis-related lncRNAs

  2025cites this paper
• Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma

  2024cites this paper
• Generality Assessment of a Model Considering Heterogeneous Cancer Cells for Predicting Tumor Control Probability for Stereotactic Body Radiation Therapy Against Non-Small Cell Lung Cancer

  2024cites this paper
• Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor

  2024influential citation
• IQGAP3 activates Hedgehog signaling to confer stemness and metastasis via up-regulating GLI1 in lung cancer

  2024cites this paper
• MACC1 ablation suppresses the dedifferentiation process of non-CSCs in lung cancer through stabilizing KLF4

  2024cites this paper
• Anti-angiogenic effect of Bryopsis plumosa-derived peptide via aquaporin 3 in non-small cell lung cancer

  2024cites this paper
• MiR-21-5p Modulates Cisplatin-Resistance of CD44+ Gastric Cancer Stem Cells Through Regulating the TGF-β2/SMAD Signaling Pathway

  2024cites this paper
• Development of a prognostic model for NSCLC based on differential genes in tumour stem cells

  2024cites this paper
• Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies

  2024cites this paper
• Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy

  2024cites this paper
• Hypoxia differently regulates the proportion of ALDHhi cells in lung squamous carcinoma H520 and adenocarcinoma A549 cells via the Wnt/β‐catenin pathway

  2024cites this paper
• Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer

  2024cites this paper
• Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer

  2024cites this paper
• Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling pathway

  2024cites this paper
• Comprehensive analysis of the role of a four-gene signature based on EMT in the prognosis, immunity, and treatment of lung squamous cell carcinoma

  2023cites this paper
• The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance

  2023cites this paper
• The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies

  2023cites this paper
• Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics

  2023cites this paper
• The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications

  2023cites this paper
• Cancer stem cells and their niche in cancer progression and therapy

  2023cites this paper
• The strategies to cure cancer patients by eradicating cancer stem-like cells

  2023cites this paper
• A circRNA-based ceRNA network shows its diagnostic value in non-small cell lung cancer.

  2023cites this paper
• 3D cell subculturing pillar dish for pharmacogenetic analysis and high-throughput screening

  2023cites this paper
• Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (Review)

  2023cites this paper
• Calycosin inhibits gemcitabine-resistant lung cancer cells proliferation through modulation of the LDOC1/GNL3L/NFκB

  2023cites this paper
• Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance

  2023cites this paper
• The Role of ARHGAP1 in Rho GTPase Inactivation during Metastasizing of Breast Cancer Cell Line MCF-7 after Treatment with Doxorubicin

  2023cites this paper
• Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer

  2023cites this paper
• Endoplasmic reticulum stress-related gene model predicts prognosis and guides therapies in lung adenocarcinoma

  2023cites this paper
• Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems

  2023cites this paper
• UVRAG Promotes Tumor Progression through Regulating SP1 in Colorectal Cancer

  2023cites this paper
• Inhibitory Effect and Mechanism of Ursolic Acid on Cisplatin-Induced Resistance and Stemness in Human Lung Cancer A549 Cells

  2023cites this paper
• TIM-4 orchestrates mitochondrial homeostasis to promote lung cancer progression via ANXA2/PI3K/AKT/OPA1 axis

  2023cites this paper
• Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance

  2023cites this paper
• Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.

  2022cites this paper
• Active Targeting of Versatile Nanocomplex Using the Novel Biomarker of Breast Cancer Stem Cells

  2022cites this paper
• Ligand‐independent EphA2 contributes to chemoresistance in small‐cell lung cancer by enhancing PRMT1‐mediated SOX2 methylation

  2022cites this paper
• The road of NSCLC stem cells toward bone metastases

  2022cites this paper
• A gene signature is critical for intrahepatic cholangiocarcinoma stem cell self-renewal and chemotherapeutic response

  2022cites this paper
• Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma

  2022cites this paper
• Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer.

  2022cites this paper
• Molecular markers in cancer.

  2022cites this paper
• The Concept and Mechanisms of Metastasis

  2022cites this paper
• A novel EHD1/CD44/Hippo/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma

  2022cites this paper
• LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway

  2022cites this paper
• The molecular mechanism of METTL3 promoting the malignant progression of lung cancer

  2022cites this paper
• Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness

  2022cites this paper
• Abnormal lipid synthesis as a therapeutic target for cancer stem cells

  2022cites this paper
• Identification and Validation Prognostic Impact of MiRNA-30a-5p in Lung Adenocarcinoma

  2022cites this paper
• PLOD3 regulates the expression of YAP1 to affect the progression of non-small cell lung cancer via the PKCδ/CDK1/LIMD1 signaling pathway

  2022cites this paper
• Potential Role of GST-π in Lung Cancer Stem Cell Cisplatin Resistance

  2021cites this paper
• Gefitinib reduces oocyte quality by disturbing meiotic progression.

  2021cites this paper
• Bioimaging of Mesenchymal Stem Cells Spatial Distribution and Interactions with 3D In Vitro Tumor Spheroids.

  2021cites this paper
• LncRNA NEAT1 contributes to the acquisition of a tumor like-phenotype induced by PM 2.5 in lung bronchial epithelial cells via HIF-1α activation

  2021cites this paper
• Role of cancer-associated fibroblasts in the resistance to antitumor therapy, and their potential therapeutic mechanisms in non-small cell lung cancer

  2021cites this paper
• The Role and Molecular Mechanism of SLC34A2 in Stemness Maintenance of CD44+CD166+ Lung Cancer Stem Cells (LCSCs) with AT-II cells’ characteristics

  2021cites this paper
• SHP2 inhibition enhances the anticancer effect of Osimertinib in EGFR T790M mutant lung adenocarcinoma by blocking CXCL8 loop mediated stemness

  2021cites this paper
• Lin28A Promotes the Amplification and Cancer Stemness of Lung Cancer Cells Via Activating MAPK Pathway Dependent on Let-7c Functions

  2021cites this paper
• Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy

  2021cites this paper
• Effect of Menadione and Combination of Gemcitabine and Cisplatin on Cancer Stem Cells in Human Non-small Cell Lung Cancer (NSCLC) Cell Line A549

  2021cites this paper
• Proteomic Analysis of Malignant Ascites From Patients With Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• SHP2 inhibition enhances the anticancer effect of Osimertinib in EGFR T790M mutant lung adenocarcinoma by blocking CXCL8 loop mediated stemness

  2021cites this paper
• Lin28A promotes the proliferation and stemness of lung cancer cells via the activation of mitogen-activated protein kinase pathway dependent on microRNA let-7c

  2021cites this paper
• Therapies approach based on metabolism of cancer stem cells

  2021cites this paper
• Vitamin D affects the Warburg effect and stemness maintenance of non-small-cell lung cancer cells by regulating PI3K/AKT/mTOR signaling pathway.

  2021cites this paper
• Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs

  2021cites this paper
• Fat1 suppresses the tumor‐initiating ability of nonsmall cell lung cancer cells by promoting Yes‐associated protein 1 nuclear‐cytoplasmic translocation

  2021influential citation
• Jaridon 6, a new diterpene from Rabdosia rubescens (Hemsl.) Hara, can display anti‐gastric cancer resistance by inhibiting SIRT1 and inducing autophagy

  2021cites this paper
• A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells.

  2021cites this paper
• Trojan-Like Peptide Drug Conjugate Design and Construction for Application in Treatment of Triple-Negative Breast Cancer.

  2021cites this paper
• Metal complexes against breast cancer stem cells.

  2021cites this paper
• The Emerging Roles of Long Noncoding RNAs as Hallmarks of Lung Cancer

  2021cites this paper
• The aqueous extract of brucea javanica reduces tumorigenicity of human lung cancer tumorspheres

  2021cites this paper
• Cancer Stem Cell for Tumor Therapy

  2021cites this paper
• Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

  2021cites this paper
• Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers

  2021influential citation
• Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma

  2021cites this paper
• The molecular mechanism of long non-coding ribonucleic acid (lncRNA) RUNX1-IT1 promotes the proliferation and stemness of lung cancer cells

  2021cites this paper
• LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway

  2021cites this paper
• Knockdown of pancreatic adenocarcinoma upregulated factor (PAUF) suppresses proliferation, migration, invasion, and cancer stem cell properties in lung cancer cells

  2021cites this paper
• Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysis

  2020cites this paper
• Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells

  2020cites this paper
• PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation

  2020cites this paper
• MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer

  2020cites this paper
• Cancer cells stemness: A doorstep to targeted therapy.

  2020cites this paper
• Hypoxia-induced Tie1 drives stemness and cisplatin resistance in non-small cell lung carcinoma cells

  2020cites this paper
• Molecular changes in EGFR downstream signalling and intracellular calcium changes associated with the cisplatin-resistant phenotype of lung cancer cells

  2020cites this paper
• Addressing cancer signal transduction pathways with antisense and siRNA oligonucleotides

  2020cites this paper